Prosecution Insights
Last updated: April 19, 2026
Application No. 19/038,164

MACHINE LEARNING MODELS FOR VEHICLE ACCIDENT POTENTIAL INJURY DETECTION

Non-Final OA §DP
Filed
Jan 27, 2025
Examiner
PAULS, JOHN A
Art Unit
3683
Tech Center
3600 — Transportation & Electronic Commerce
Assignee
State Farm Mutual Automobile Insurance Company
OA Round
1 (Non-Final)
49%
Grant Probability
Moderate
1-2
OA Rounds
3y 9m
To Grant
76%
With Interview

Examiner Intelligence

Grants 49% of resolved cases
49%
Career Allow Rate
404 granted / 829 resolved
-3.3% vs TC avg
Strong +28% interview lift
Without
With
+27.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 9m
Avg Prosecution
46 currently pending
Career history
875
Total Applications
across all art units

Statute-Specific Performance

§101
28.8%
-11.2% vs TC avg
§103
33.4%
-6.6% vs TC avg
§102
11.3%
-28.7% vs TC avg
§112
20.9%
-19.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 829 resolved cases

Office Action

§DP
DETAILED ACTION Status of Claims This action is in reply to the application filed on 27 January, 2025. Claims 1 - 20 are currently pending and have been examined. The present application is a continuation of U.S. Application Number 17/685,164 now U.S. Patent Number 12,211,620. Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Interpretation The claims recite receiving first and second data associated with a vehicle accident over time and determining a probability prediction associated with the accident. The claims are directed to collecting and analyzing data to obtain a result, which is an abstract mental process. The claims collect and analyze data to determine the probability prediction, and then transmit instructions to a target computer to initiate a process, essentially providing a notification to an appropriate organization to respond to the accident. However, the claims recite limitations that integrate the abstract idea into a practical application. For example, the claims recite a process that delays execution of the decision tree model when additional information is expected, by determining a future model execution time. The specification expressly discloses that delayed execution, as recited, saves computational resources (@ 0047, 0049 as filed). The prior art of record fails to expressly teach a method and system for determining a probability prediction associated with a motor vehicle accident by receiving and providing accident data to a machine learning model, where the claims, in combination with other recited features, includes determining a future model execution time associated with the machine learning decision tree, receiving additional data associated with the motor vehicle accident prior to the future execution time occurring, and determining the probability prediction at the future time. Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP §§ 706.02(l)(1) - 706.02(l)(3) for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/process/file/efs/guidance/eTD-info-I.jsp. Claims 1 - 20 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1 – 4, 8 and 10 - 17 of U.S. Patent No. 12,211,620 B2. Although the claims at issue are not identical, they are not patentably distinct from each other because the issued claims recite all of the limitations of the pending claims, using alternative wording. For example, the pending claims substitute the term “computing device” for the term “computer system”; substitute the term “future model execution time” for the term “delayed model execution time”; and substituting the term “probability prediction” for the term “injury probability”. These terms have the same meaning. The table below shows the pending claims and their corresponding issued claims: Pending Claims Issued Claims 1 1 2 2 3 1/3 4 14 5 15 6 1/3 7 1/4 8 8 9 10 10 11 11 12 12 13 13 12 14 14 15 15 16 12/16 17 12/17 18 8 19 10 20 11 CONCLUSION Any inquiry of a general nature or relating to the status of this application or concerning this communication or earlier communications from the Examiner should be directed to John A. Pauls whose telephone number is (571) 270-5557. The Examiner can normally be reached on Mon. - Fri. 8:00 - 5:00 Eastern. If attempts to reach the examiner by telephone are unsuccessful, the Examiner’s supervisor, Robert Morgan can be reached at (571) 272-6773. Official replies to this Office action may now be submitted electronically by registered users of the EFS-Web system. Information on EFS-Web tools is available on the Internet at: http://www.uspto.gov/patents/process/file/efs/guidance/index.jsp. An EFS-Web Quick-Start Guide is available at: http://www.uspto.gov/ebc/portal/efs/quick-start.pdf. Alternatively, official replies to this Office action may still be submitted by any one of fax, mail, or hand delivery. Faxed replies should be directed to the central fax at (571) 273-8300. Mailed replies should be addressed to “Commissioner for Patents, PO Box 1450, Alexandria, VA 22313-1450.” Hand delivered replies should be delivered to the “Customer Service Window, Randolph Building, 401 Dulany Street, Alexandria, VA 22314.” /JOHN A PAULS/Primary Examiner, Art Unit 3683 Date: 4 March, 2026
Read full office action

Prosecution Timeline

Jan 27, 2025
Application Filed
Mar 09, 2026
Non-Final Rejection — §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12586676
IMAGE INTERPRETATION MODEL DEVELOPMENT
2y 5m to grant Granted Mar 24, 2026
Patent 12586668
System and Method for Patient Care Improvement
2y 5m to grant Granted Mar 24, 2026
Patent 12567483
AUTOMATED LABELING OF USER SENSOR DATA
2y 5m to grant Granted Mar 03, 2026
Patent 12548670
EMERGENCY MANAGEMENT SYSTEM
2y 5m to grant Granted Feb 10, 2026
Patent 12548664
ADAPTIVE CONTROL OF MEDICAL DEVICES BASED ON CLINICIAN INTERACTIONS
2y 5m to grant Granted Feb 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
49%
Grant Probability
76%
With Interview (+27.5%)
3y 9m
Median Time to Grant
Low
PTA Risk
Based on 829 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month